RxDoctor Payments Data

Brooke Adams

Adult Health · Buffalo, NYNPI 1154865210

Payments from drug & device makers

$3,481in general payments, 2019–2025

Across 174 payments — averaging $20.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Novo Nordisk$520
  • GSK$371
  • Pfizer$335
  • Lilly USA, LLC$263
  • Exact Sciences$158
  • plus $702 from 13 others

What the payments were for

  • Food & beverage$3,481100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,481 in reported general payments places this provider in the 85th percentile of 3,828 adult health providers in New York.

See all adult health providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol77$72,891
JardianceEmpagliflozin66$46,940
Trelegy ElliptaFluticasone/Umeclidin/Vilanter53$41,856
EliquisApixaban49$39,364
KerendiaFinerenone35$34,643
RybelsusSemaglutide29$32,885
OzempicSemaglutide30$31,803
TrulicityDulaglutide28$31,259
Breztri AerosphereBudesonide/Glycopyr/Formoterol32$24,275
MounjaroTirzepatide15$16,961
Repatha SureclickEvolocumab25$15,553
Hysingla ErHydrocodone Bitartrate12$15,139
MyrbetriqMirabegron13$14,890
LinzessLinaclotide15$14,002
Nurtec OdtRimegepant Sulfate11$12,791

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$1,131$107,354141 claims
Novo NordiskRybelsus, Ozempic$520$64,68859 claims
PfizerEliquis, Nurtec Odt$335$52,15660 claims
Lilly USA, LLCTrulicity, Mounjaro$263$48,22143 claims
GSKTrelegy Ellipta$371$41,85653 claims
BayerKerendia$49$34,64335 claims
AbbVieLinzess$156$14,00215 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,828 adult health providers in New York.

Other adult health in Buffalo

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →